Merck Consolidated Income Statement Audited

Sales

[22]

10,740.8

9,905.9

Royalty, license and commission income

[23]

432.1

370.5

Total revenues

11,172.9

10,276.4

Cost of sales

[24]

–3,157.7

–2,785.6¹

Gross margin

8,015.2

7,490.8¹

Marketing and selling expenses

[25]

–2,410.8

–2,385.7¹

Royalty, license and commission expenses

[26]

–579.8

–500.5

Administration expenses

[27]

–552.2

–535.6¹

Other operating expenses and income

[28]

–1,126.5

–417.2¹

Research and development

[30]

–1,511.3

–1,514.0¹

Amortization of intangible assets

[31]

–871.6

–1,004.7

Investment result

[32]

0.6

–1.0

Operating result

963.6

1,132.1¹

Financial result

[33]

–254.6

–293.3¹

Profit before income tax

709.0

838.8¹

Income tax

[34]

–130.0

–220.8¹

Profit after tax

579.0

618.0¹

of which attributable to Merck KGaA shareholders (net income)

566.7

606.5¹

of which attributable to non-controlling interest

[35]

12.3

11.5

basic

2.61

2.79¹

diluted

2.61

2.79¹